Status:

COMPLETED

Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease

Lead Sponsor:

Stanford University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Peripheral Vascular Diseases

Eligibility:

All Genders

40+ years

Brief Summary

Atherosclerosis, a condition in which fatty deposits build up along the inner walls of arteries, can occur throughout the body. The purpose of this study is to examine the possible genetic differences...

Detailed Description

Plaque build-up caused by atherosclerosis increases the risk of blood clots, heart attack, and stroke. Blockages of plaque can occur in different areas of the body. PAD, a circulatory disorder in whic...

Eligibility Criteria

Inclusion

  • Hemodynamically significant PAD, as documented by an ankle-brachial index less than 0.9; control group participants will not have PAD
  • Received a referral for an elective coronary angiogram
  • Suspected CAD

Exclusion

  • History of radiation treatment
  • History of organ transplant
  • History of viral diseases (i.e. HIV, hepatitis)

Key Trial Info

Start Date :

April 1 2004

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

1789 Patients enrolled

Trial Details

Trial ID

NCT00380185

Start Date

April 1 2004

Last Update

May 28 2015

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Stanford University

Stanford, California, United States, 94305

2

Mt. Sinai Medical Center

New York, New York, United States, 10029

Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease | DecenTrialz